(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TWINSTRAND DUPLEX SEQUENCING

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TWINSTRAND DUPLEX SEQUENCING

ST13

US500000088126985

Class

1, 9, 42

Filing

88126985

Registration

7031242

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

04/21/2023

Trademark type

Word

Nice classes

1, 9, 42

Filing date

09/21/2018

Registration date

04/18/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/18/2023

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2020-02-00

First use in commerce

2020-02-00

Drawing code

4

Owner type

03

Owner location

Seattle, WA

Examiner

BUTLER, MIDGE

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

TwinStrand Biosciences, Inc.

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 1Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

kits comprising primarily of regentsenzymes and nucleotides for genetic researchnon-medical human identificationmedical and scientific research; reagentsenzymesnucleotides for scientific or medical research use; reagentsenzymesnucleotides for nucleic acid sequencing for scientific or medical research purposes; reagents for scientific or medical usereagents for use in preparation of DNA sequencing samples

Class 9

computer software for scientific and medical analysis of genetic sequences; computer software for nucleic acid sequencing and genotyping in the fields of medical researchclinical researchmolecular pathologybiotechnologyoncologygeneticspharmacologygenotoxicitycarcinogenesis; computer software for receivingprocessingtransmitting and displaying data for use in genetic analysis

Class 42

Nucleic acid sequencing and analysis services for scientific and research purposes; genome sequencing and analysis services for scientific and research purposes; genetic analysis and reporting services for scientific and research purposes; genome sequencing and analysis services for genotoxicity purposes; structural and functional analysis of genomes; medical and scientific research in the field of cancer detectiondiagnosis and monitoring; providing medical and scientific information in the fields of pharmaceuticals and genetics; pharmaceutical research and development services; providing temporary use of non-downloadable computer software for scientific and medical analysis of genetic sequences; providing temporary use of non-downloadable computer software for nucleic acid sequencing and genotyping in the fields of medical diagnosticsmedical researchclinical researchmolecular pathologybiotechnologyoncologygeneticspharmacologygenotoxicitycarcinogenesis

Publications

History of USPTO decisions and trademark events.

46 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/18/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/18/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/14/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/13/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/06/2023

HSCD

HIDDEN SENSITIVE CONTENT

07/11/2022

PCGR

PETITION TO DIRECTOR GRANTED

07/10/2022

APET

ASSIGNED TO PETITION STAFF

07/08/2022

APET

ASSIGNED TO PETITION STAFF

06/28/2022

TPDR

TEAS PETITION TO DIRECTOR RECEIVED

04/25/2022

IUAF

USE AMENDMENT FILED

04/11/2022

EISU

TEAS STATEMENT OF USE RECEIVED

04/11/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/08/2021

EX5G

SOU EXTENSION 5 GRANTED

10/07/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/04/2021

EXT5

SOU EXTENSION 5 FILED

09/28/2021

EEXT

SOU TEAS EXTENSION RECEIVED

09/28/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/07/2021

EX4G

SOU EXTENSION 4 GRANTED

04/05/2021

EXT4

SOU EXTENSION 4 FILED

04/05/2021

EEXT

SOU TEAS EXTENSION RECEIVED

04/05/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/13/2020

EX3G

SOU EXTENSION 3 GRANTED

10/09/2020

EXT3

SOU EXTENSION 3 FILED

10/09/2020

EEXT

SOU TEAS EXTENSION RECEIVED

10/09/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/03/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/03/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/03/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/03/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/07/2020

EX2G

SOU EXTENSION 2 GRANTED

04/03/2020

EXT2

SOU EXTENSION 2 FILED

04/03/2020

EEXT

SOU TEAS EXTENSION RECEIVED

04/03/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/08/2019

EX1G

SOU EXTENSION 1 GRANTED

10/04/2019

EXT1

SOU EXTENSION 1 FILED

10/04/2019

EEXT

SOU TEAS EXTENSION RECEIVED

10/04/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/09/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/12/2019

PUBO

PUBLISHED FOR OPPOSITION

02/12/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/23/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2019

DOCK

ASSIGNED TO EXAMINER

01/03/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/28/2018

NWAP

NEW APPLICATION ENTERED

09/25/2018

Continuous trademark protection

Get notified about every new filing that threatens TWINSTRAND DUPLEX SEQUENCING or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.